Cochlear Limited
CHEOY | OTC
$47.76
-$2.50 (-4.97%)
Nov 2, 2026, 9:30 AM ET · Market open
Company Profile
Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items. Founded in 1981, Cochlear Limited is headquartered in Sydney, Australia.
Key Executives
| Name | Position |
|---|---|
| Diggory William Howitt | Chief Executive Officer, MD, President & Executive Director |
| Jan Janssen Elec | Chief Technology Officer |
| Karen O'Driscoll | Chief Information Officer |
| Sabina Sopov | Chief People Officer, Global People & Culture |
| Sarah Thom | Chief Financial Officer |
| Anthony Bishop | President of EMEA |
| Brian Kaplan | Senior Vice President of Global Clinical Strategy & Innovation |
| Dean Phizacklea | Senior Vice President of Global Strategic Marketing |
| Greg Bodkin MComm | Senior Vice President of Global Supply Chain |
| Jennifer Hornery | Senior Vice President of Global People & Culture |
| Jennifer Stevenson | Vice President of Corporate Communications & Brand |
| Jennifer Stewart | Vice President of Communications, Brand & Digital Marketing |
| Kimberley Simpson | Head of Group Tax |
| Kristina Devon | Vice President of Corporate Strategy & Investor Relations |
| Kristy Jo | Company Secretary |
| Lisa Aubert | President of North America |
| Rob McGrory | Group General Counsel & Company Secretary |
| Stuart Sayers | President of Asia Pacific & Latin America |
Cochlear Limited
| Country | Australia |
| IPO Date | Apr 5, 2010 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 5,400 |
| CEO | Diggory William Howitt |
Contact Details
1 University Avenue Sydney,
NSW 2109 Australia
Stock Details
| Ticker Symbol | CHEOY |
| Exchange | OTC |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | 191459205 |
| ISIN Number | US1914592050 |
| SIC Code | n/a |
Recent News
- 7 days ago / seekingalpha.comCochlear Limited (CHEOY) Shareholder/Analyst Call Prepared Remarks Transcript
- 1 month ago / businesswire.comCochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research Program
- 3 months ago / seekingalpha.comCochlear Limited (CHEOY) Q4 2026 Earnings Call Transcript
- 4 months ago / newsfilecorp.comEnvoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant
Add to Watchlist
Select watchlists to add or remove CHEOY